Douglas Faller's most recent trade in Imunon Inc was a trade of 3,082 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on July 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Inc | Douglas Faller | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.83 per share. | 17 Jul 2026 | 3,082 | 26,286 (0%) | 0% | 1.8 | 5,640 | Common Stock |
| Imunon Inc | Douglas Faller | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.91 per share. | 02 Jul 2026 | 1,308 | 23,204 (0%) | 0% | 1.9 | 2,498 | Common Stock |
| Imunon Inc | Douglas Faller | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 25 Jun 2026 | 21,896 | 21,896 (0%) | 0% | 1.7 | 37,661 | Common Stock |
| Imunon Inc | Douglas Faller | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 12,667 | 12,667 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Douglas Faller | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |